BRADENTON, Fla., Aug. 6, 2025 /CNW/ -- Continuity Biosciences, a company pioneering next-generation combination product drug delivery, today announced the appointment of two highly distinguished leaders to its Board of Directors: Josephine M. Torrente, Director at Hyman, Phelps & McNamara, P.C., and Dr. Joseph M. DeSimone, serial entrepreneur and professor at Stanford University. These appointments mark a significant step forward in Continuity's mission to advance transformative drug delivery technologies, supported by world-class regulatory expertise and materials science innovation.
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/Micron%20Technology%20Inc_billboard-by%20Poetra_RH%20via%20Shutterstock.jpg)
/Microsoft%20France%20headquarters%20by%20JeanLuclchard%20via%20Shutterstock.jpg)
/International%20Business%20Machines%20Corp_%20logo%20on%20storage%20rack-by%20Nick%20N%20A%20via%20Shutterstock.jpg)
/Palantir%20(PLTR)%20by%20Piotr%20Swat%20via%20Shutterstock.jpg)